DEA, DEA, EPA have announced that they plan to protect herbal and medicinal plants, according to a joint statement from the three agencies.
The DEA, in a joint press release on Friday, said it will make it harder for DEA-authorized companies to market their products to consumers and that it will require manufacturers to post warnings about the dangers of the products on their labels.
“There’s a risk that people are going to mistake these herbal and herbal products for drugs or dangerous chemicals, which can cause serious side effects,” said DEA Special Agent in Charge Kevin C. Toth, in the statement.
He said the DEA will also make it easier for states to regulate the use of herbal and/or medicinal products.
It is also expected that the DEA, which regulates the trade of the plant, will take steps to prohibit the use, production, sale and transportation of herbal, medicinal, and other cannabis products.
The DEA will consider legislation that would provide that cannabis be classified as a Schedule I controlled substance, or a class of drugs with no currently accepted medical use and a high potential for abuse, according the joint statement.
The U.S. Justice Department and the Drug Enforcement Administration will conduct a study of the impact of the proposed regulations and submit a report to the White House by mid-March, the joint press statement said.